The Joint (JYNT) Stock: Buy, Sell, or Hold?
JYNT - The Joint Corp.
$8.63
0.16 (1.89%)
▲
5d:
+6.67%
30d:
+2.74%
90d:
-6.6%
BUY
HIGH Confidence
Analysis Updated: Sep 16, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When JYNT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: JYNT appears deeply undervalued. Market expects -20.7% annual earnings decline despite 653% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: JYNT appears deeply undervalued. Market expects -20.7% annual earnings decline despite 653% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$30.91
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$19.20
55.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: JYNT is currently trading at $8.63, which is considered extended relative to its 30-day fair value range of $8.19 to $8.56. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.6) compared to its historical average (27.2). Remarkably, the market is currently pricing in an annual earnings decline of 20.7% over the next few years. This pessimistic expectation contrasts with the company's recent 652.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, JYNT is in a downtrend. The price is approaching resistance at $8.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: JYNT scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (19th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.00 (+15.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, JYNT is in a downtrend. The price is approaching resistance at $8.67. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: JYNT scores 74/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (19th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.00 (+15.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$8.19 -
$8.56
Company Quality Score
55/100
(HOLD)
Options IV Signal
19th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
67.3%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 19th percentile)
- BULLISH: Strong technical setup (74/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($10.00)
- BULLISH: Bottoming setup score 74/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$8.19 -
$8.56
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.96
(11.1%)
Support & Resistance Levels
Support Level
$7.81
Resistance Level
$8.67
Current Trend
Downtrend
Technical data as of
Sep 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.59
Wall Street Target
$10.00
(+15.9%)
Revenue Growth (YoY)
14.4%
Earnings Growth (YoY)
652.6%
Profit Margin
6.5%
Valuation Discount vs History
-20.7% cheaper
PE vs Historical
13.6 vs 27.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-20.7%
(market-implied from PE analysis)
1-Year Target
$7.77
(-10%)
2-Year Target
$6.99
(-19%)
3-Year Target
$6.29
(-27%)
3-Yr Target (if PE normalizes)
(PE: 14→27)
$12.59
(+46%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 388.5%)
$43.27
(+401%)
Base:
(SPY PE: 13.6, Growth: 388.5%)
$29.13
(+238%)
Bear:
(PE: 11.6, Growth: 388.5%)
$24.76
(+187%)
📈
Valuation based on Current Earnings
Forward PE: 11.81 | Forward EPS (Implied): $0.73
Bull Case
$10.42
(+21%)
Analyst growth 15.0%, PE expands to 12.4
Base Case
$8.63
(0%)
Market implied 0.0%, PE stable at 11.8
Bear Case
$6.60
(-24%)
Severe decline -15.0%, PE contracts to 10.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.6 to 27.2
Stabilization Target:
$17.27
(+100.1%)
PE Expansion Potential:
+100.1%
Share & Embed Analysis
Last updated: September 17, 2026 5:14 AM ET
Data refreshes hourly during market hours. Next update: 6:14 AM
Data refreshes hourly during market hours. Next update: 6:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JYNT showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Charles E Jobson
BUY
509 shares
2026-04-21
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 52 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 58 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 54 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 44 HOLD |
Advanced JYNT Option Strategies
Professional options setups generated by AI based on today's JYNT price and gamma walls.
